We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$712B
AUM Growth
+$31.8B
Cap. Flow
+$2.48B
Cap. Flow %
0.35%
Top 10 Hldgs %
21.18%
Holding
2,600
New
72
Increased
1,394
Reduced
949
Closed
59

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.27B
2
LLY icon
Eli Lilly
LLY
+$1.64B
3
NVDA icon
NVIDIA
NVDA
+$1.59B
4
RHT
Red Hat Inc
RHT
+$1.55B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Healthcare 16.96%
3 Financials 13.79%
4 Consumer Discretionary 13.57%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLCO icon
2376
Melco Resorts & Entertainment
MLCO
$2.14B
$232K ﹤0.01%
10,700
PGEN icon
2377
Precigen
PGEN
$2.45B
$231K ﹤0.01%
30,095
+200
+0.7% +$1.08K
BCE icon
2378
BCE
BCE
$21.6B
$228K ﹤0.01%
5,000
CASI
2379
DELISTED
CASI Pharmaceuticals
CASI
$226K ﹤0.01%
7,067
+10
+0.1% +$319
PFBI
2380
DELISTED
Premier Financial Bancorp
PFBI
$226K ﹤0.01%
15,099
MDY icon
2381
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
$224K ﹤0.01%
631
-123
-16% -$43K
WSR
2382
DELISTED
Whitestone REIT
WSR
$224K ﹤0.01%
17,616
+100
+0.6% +$1.25K
MHH icon
2383
Mastech Digital
MHH
$92.7M
$222K ﹤0.01%
46,784
NFBK
2384
DELISTED
Northfield Bancorp
NFBK
$222K ﹤0.01%
14,224
+137
+1% +$2.05K
WTI icon
2385
W&T Offshore
WTI
$555M
$222K ﹤0.01%
44,856
+100
+0.2% +$539
RY icon
2386
Royal Bank of Canada
RY
$297B
$220K ﹤0.01%
2,770
CALA
2387
DELISTED
Calithera Biosciences, Inc
CALA
$220K ﹤0.01%
2,816
+5
+0.2% +$567
ALG icon
2388
Alamo Group
ALG
$2.01B
$219K ﹤0.01%
2,187
+26
+1% +$2.59K
RDNT icon
2389
RadNet
RDNT
$6.06B
$219K ﹤0.01%
15,914
+192
+1% +$2.46K
RFL icon
2390
Rafael Holdings
RFL
$103M
$218K ﹤0.01%
+7,677
New +$132K
INFI
2391
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$216K ﹤0.01%
120,206
SWN
2392
DELISTED
Southwestern Energy Company
SWN
$214K ﹤0.01%
67,716
+250
+0.4% +$971
TEN
2393
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$213K ﹤0.01%
19,218
+100
+0.5% +$1.63K
HPR
2394
DELISTED
HighPoint Resources Corporation
HPR
$213K ﹤0.01%
2,340
+4
+0.2% +$446
NCMI icon
2395
National CineMedia
NCMI
$208M
$212K ﹤0.01%
3,234
+20
+0.6% +$1.41K
CVGI icon
2396
Commercial Vehicle Group
CVGI
$128M
$211K ﹤0.01%
26,304
ARLO icon
2397
Arlo Technologies
ARLO
$1.5B
$209K ﹤0.01%
52,036
+100
+0.2% +$393
CIVI
2398
DELISTED
Civitas Resources
CIVI
$209K ﹤0.01%
10,009
+35
+0.4% +$765
MBUU icon
2399
Malibu Boats
MBUU
$576M
$209K ﹤0.01%
5,378
+42
+0.8% +$1.67K
PSEC icon
2400
PUT
Prospect Capital
PSEC
$1.15B
$208K ﹤0.01%
31,800

Similar funds

T. Rowe Price Associates's Q2 2019 Portfolio in Review

As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
  • T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
  • T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
  • T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
  • T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
  • T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.